Healixa Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EMOR research report →
Companyhealixa.com
Healixa Inc. operates as a technology company with assets in both healthtech and fintech. It offers tech solutions to enterprise partner channels across a range of industries, including employer benefits, travel, pharma, logistics, and other.
- CEO
- Ian Parker
- IPO
- 2010
- Employees
- 15
- HQ
- Holbrook, NY, US
Price Chart
Valuation
- Market Cap
- $38.30M
- P/E
- -70.30
- P/S
- 66.62
- P/B
- -3.81
- EV/EBITDA
- -156.84
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 67.04%
- Op Margin
- -51.61%
- Net Margin
- -94.82%
- ROE
- 5.52%
- ROIC
- 8.57%
Growth & Income
- Revenue
- $702.91K · 17.37%
- Net Income
- $-756,898 · 88.75%
- EPS
- $-0.00 · 88.51%
- Op Income
- $-475,131
- FCF YoY
- 69.82%
Performance & Tape
- 52W High
- $0.07
- 52W Low
- $0.01
- 50D MA
- $0.04
- 200D MA
- $0.02
- Beta
- 0.09
- Avg Volume
- 7.28K
Get TickerSpark's AI analysis on EMOR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EMOR Coverage
We haven't published any research on EMOR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EMOR Report →